Purchases and Sales Made in Q4 2024 in Fate Therapeutics Inc (FATE)
This table provides information about the institutional ownership of Fate Therapeutics Inc (FATE) during Q4 2024. The information is specifically focused on institutions that hold shares of FATE THERAPEUTICS INC.
| Report Date | Institution (Fund) | Operation | Option | Shares change | Value Range | Shares Held | Trade History |
|---|---|---|---|---|---|---|---|
|
Feb 11, 2025
Q4 2024
|
Vanguard Group Inc
Valley Forge, PA |
SELL
|
- |
-71.1K- 0.68% |
$114K - $238K
|
10.3M
$10.6M
|
|
|
Feb 14, 2025
Q4 2024
|
Ameriprise Financial Inc
Minneapolis, MN |
SELL
|
- |
-72.6K- 29.06% |
$117K - $243K
|
177K
$182K
|
|
|
Feb 14, 2025
Q4 2024
|
California State Teachers Retirement System
West Sacramento, CA |
SELL
|
- |
-74.5K- 91.13% |
$120K - $250K
|
7.25K
$7.47K
|
|
|
Feb 14, 2025
Q4 2024
|
Superstring Capital Management LP
New York, NY |
SELL
|
- |
-87.4K- 5.96% |
$141K - $293K
|
1.38M
$1.42M
|
|
|
Feb 13, 2025
Q4 2024
|
Legal & General Group PLC
London, X0 |
SELL
|
- |
-94.4K- 91.61% |
$152K - $316K
|
8.64K
$8.9K
|
|
|
Feb 14, 2025
Q4 2024
|
David A. Siegel
Two Sigma Advisers, LP | New York, Ny
|
SELL
|
- |
-99.1K- 10.69% |
$160K - $332K
|
828K
$853K
|
|
|
Feb 14, 2025
Q4 2024
|
Jane Street Group, LLC
New York, NY |
SELL
|
- |
-117K- 79.18% |
$189K - $392K
|
30.8K
$31.7K
|
|
|
Feb 11, 2025
Q4 2024
|
Acadian Asset Management LLC
Boston, MA |
SELL
|
- |
-128K- 8.01% |
$207K - $430K
|
1.47M
$1.52M
|
|
|
Feb 14, 2025
Q4 2024
|
Susquehanna Fundamental Investments, LLC
Bala Cynwyd, PA |
SELL
|
- |
-144K- 54.96% |
$232K - $483K
|
118K
$122K
|
|
|
Feb 14, 2025
Q4 2024
|
Two Sigma Investments, LP
New York, NY |
SELL
|
- |
-162K- 35.35% |
$262K - $544K
|
297K
$306K
|
|
|
Feb 12, 2025
Q4 2024
|
Jpmorgan Chase & CO
New York, NY |
SELL
|
- |
-168K- 9.13% |
$270K - $562K
|
1.67M
$1.72M
|
|
|
Feb 14, 2025
Q4 2024
|
Hrt Financial LP
New York, NY |
SELL
|
- |
-180K- 86.05% |
$290K - $603K
|
29.2K
$30K
|
|
|
Feb 14, 2025
Q4 2024
|
Morgan Stanley
New York, NY |
SELL
|
- |
-241K- 7.87% |
$388K - $808K
|
2.82M
$2.91M
|
|
|
Feb 14, 2025
Q4 2024
|
Redmile Group, LLC
San Francisco, CA |
SELL
|
- |
-296K- 2.25% |
$477K - $992K
|
12.9M
$13.3M
|
|
|
Feb 11, 2025
Q4 2024
|
Goldman Sachs Group Inc
New York, NY |
SELL
|
- |
-347K- 12.29% |
$559K - $1.16M
|
2.48M
$2.55M
|
|
|
Feb 14, 2025
Q4 2024
|
Integral Health Asset Management, LLC
|
SELL
|
- |
-375K- 38.46% |
$604K - $1.26M
|
600K
$618K
|
|
|
Feb 14, 2025
Q4 2024
|
Bank Of America Corp
Charlotte, NC |
SELL
|
- |
-550K- 64.4% |
$886K - $1.84M
|
304K
$313K
|
|
|
Feb 14, 2025
Q4 2024
|
Woodline Partners LP
San Francisco, CA |
SELL
|
- |
-1.64M- 53.59% |
$2.65M - $5.5M
|
1.42M
$1.47M
|
|
|
Feb 14, 2025
Q4 2024
|
D. E. Shaw & Co., Inc.
New York, NY |
SELL
|
- |
-1.84M- 54.51% |
$2.96M - $6.17M
|
1.54M
$1.58M
|
|
|
Jan 14, 2025
Q4 2024
|
Assenagon Asset Management S.A.
|
SELL
|
- |
-2.06M- 84.7% |
$3.32M - $6.91M
|
373K
$384K
|
|
|
Feb 14, 2025
Q4 2024
|
State Street Corp
Boston, MA |
SELL
|
- |
-3.03M- 57.6% |
$4.87M - $10.1M
|
2.23M
$2.29M
|